Covalon Technologies Ltd. (COV) - Net Assets
Based on the latest financial reports, Covalon Technologies Ltd. (COV) has net assets worth CA$30.73 Million CAD (≈ $22.23 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$36.12 Million ≈ $26.13 Million USD) and total liabilities (CA$5.40 Million ≈ $3.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Covalon Technologies Ltd. (COV) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$30.73 Million |
| % of Total Assets | 85.06% |
| Annual Growth Rate | 11.03% |
| 5-Year Change | -7.93% |
| 10-Year Change | 706.91% |
| Growth Volatility | 77.55 |
Covalon Technologies Ltd. - Net Assets Trend (2005–2025)
This chart illustrates how Covalon Technologies Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore COV asset base for the complete picture of this company's asset base.
Annual Net Assets for Covalon Technologies Ltd. (2005–2025)
The table below shows the annual net assets of Covalon Technologies Ltd. from 2005 to 2025. For live valuation and market cap data, see Covalon Technologies Ltd. stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | CA$30.73 Million ≈ $22.23 Million |
+11.72% |
| 2024-09-30 | CA$27.50 Million ≈ $19.90 Million |
+46.36% |
| 2023-09-30 | CA$18.79 Million ≈ $13.59 Million |
-22.44% |
| 2022-09-30 | CA$24.23 Million ≈ $17.53 Million |
-27.40% |
| 2021-09-30 | CA$33.37 Million ≈ $24.14 Million |
+266.48% |
| 2020-09-30 | CA$9.11 Million ≈ $6.59 Million |
-39.00% |
| 2019-09-30 | CA$14.93 Million ≈ $10.80 Million |
+13.76% |
| 2018-09-30 | CA$13.12 Million ≈ $9.49 Million |
+46.14% |
| 2017-09-30 | CA$8.98 Million ≈ $6.50 Million |
+135.85% |
| 2016-09-30 | CA$3.81 Million ≈ $2.75 Million |
-20.43% |
| 2015-09-30 | CA$4.79 Million ≈ $3.46 Million |
-13.42% |
| 2014-09-30 | CA$5.53 Million ≈ $4.00 Million |
+87.61% |
| 2013-09-30 | CA$2.95 Million ≈ $2.13 Million |
-8.91% |
| 2012-09-30 | CA$3.23 Million ≈ $2.34 Million |
-53.89% |
| 2011-09-30 | CA$7.02 Million ≈ $5.07 Million |
-7.33% |
| 2010-09-30 | CA$7.57 Million ≈ $5.48 Million |
-30.81% |
| 2009-09-30 | CA$10.94 Million ≈ $7.91 Million |
-27.13% |
| 2008-09-30 | CA$15.02 Million ≈ $10.86 Million |
-14.65% |
| 2007-09-30 | CA$17.59 Million ≈ $12.73 Million |
+112.84% |
| 2006-09-30 | CA$8.27 Million ≈ $5.98 Million |
+117.95% |
| 2005-09-30 | CA$3.79 Million ≈ $2.74 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Covalon Technologies Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2659390800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$64.37 Million | 209.48% |
| Total Equity | CA$30.73 Million | 100.00% |
Covalon Technologies Ltd. Competitors by Market Cap
The table below lists competitors of Covalon Technologies Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jinli Group Holdings Ltd
TW:8429
|
$38.51 Million |
|
Ascent Solar Technologies, Inc. Common Stock
NASDAQ:ASTI
|
$38.51 Million |
|
Kafein Yazilim
IS:KFEIN
|
$38.53 Million |
|
Li Kang Biomedical Co Ltd
TWO:6242
|
$38.53 Million |
|
Genoray Co. Ltd
KQ:122310
|
$38.45 Million |
|
Corem Property Group AB (publ)
ST:CORE-A
|
$38.44 Million |
|
Mentice AB
ST:MNTC
|
$38.44 Million |
|
Caprice Resources Ltd
AU:CRS
|
$38.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Covalon Technologies Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,504,608 to 30,726,909, a change of 3,222,301 (11.7%).
- Net income of 2,058,089 contributed positively to equity growth.
- Other comprehensive income decreased equity by 3,130,413.
- Other factors increased equity by 4,294,625.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$2.06 Million | +6.7% |
| Other Comprehensive Income | CA$-3.13 Million | -10.19% |
| Other Changes | CA$4.29 Million | +13.98% |
| Total Change | CA$- | 11.72% |
Book Value vs Market Value Analysis
This analysis compares Covalon Technologies Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.73x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.05x to 1.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-09-30 | CA$0.95 | CA$1.94 | x |
| 2006-09-30 | CA$1.69 | CA$1.94 | x |
| 2007-09-30 | CA$2.98 | CA$1.94 | x |
| 2008-09-30 | CA$2.04 | CA$1.94 | x |
| 2009-09-30 | CA$1.47 | CA$1.94 | x |
| 2010-09-30 | CA$1.01 | CA$1.94 | x |
| 2011-09-30 | CA$0.84 | CA$1.94 | x |
| 2012-09-30 | CA$0.39 | CA$1.94 | x |
| 2013-09-30 | CA$0.32 | CA$1.94 | x |
| 2014-09-30 | CA$0.59 | CA$1.94 | x |
| 2015-09-30 | CA$0.51 | CA$1.94 | x |
| 2016-09-30 | CA$0.32 | CA$1.94 | x |
| 2017-09-30 | CA$0.45 | CA$1.94 | x |
| 2018-09-30 | CA$0.57 | CA$1.94 | x |
| 2019-09-30 | CA$0.66 | CA$1.94 | x |
| 2020-09-30 | CA$0.35 | CA$1.94 | x |
| 2021-09-30 | CA$1.29 | CA$1.94 | x |
| 2022-09-30 | CA$0.94 | CA$1.94 | x |
| 2023-09-30 | CA$0.76 | CA$1.94 | x |
| 2024-09-30 | CA$1.13 | CA$1.94 | x |
| 2025-09-30 | CA$1.12 | CA$1.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Covalon Technologies Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.70%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.27%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 1.18x
- Recent ROE (6.70%) is above the historical average (-26.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -49.08% | 0.00% | 0.00x | 1.19x | CA$-2.24 Million |
| 2006 | -26.68% | -234.87% | 0.11x | 1.06x | CA$-3.03 Million |
| 2007 | -17.49% | -239.28% | 0.06x | 1.15x | CA$-4.84 Million |
| 2008 | -24.91% | -151.27% | 0.14x | 1.15x | CA$-5.24 Million |
| 2009 | -44.55% | -213.29% | 0.18x | 1.18x | CA$-5.97 Million |
| 2010 | -51.98% | -121.78% | 0.31x | 1.36x | CA$-4.69 Million |
| 2011 | -50.77% | -137.63% | 0.28x | 1.33x | CA$-4.26 Million |
| 2012 | -123.40% | -105.22% | 0.64x | 1.84x | CA$-4.31 Million |
| 2013 | -33.71% | -24.02% | 0.73x | 1.92x | CA$-1.29 Million |
| 2014 | 43.45% | 26.51% | 1.14x | 1.44x | CA$1.85 Million |
| 2015 | -19.68% | -12.41% | 0.99x | 1.59x | CA$-1.42 Million |
| 2016 | -81.28% | -46.12% | 1.03x | 1.70x | CA$-3.48 Million |
| 2017 | 20.17% | 6.63% | 2.28x | 1.33x | CA$913.59K |
| 2018 | 12.33% | 6.05% | 1.36x | 1.50x | CA$305.17K |
| 2019 | -61.20% | -26.87% | 0.86x | 2.65x | CA$-10.63 Million |
| 2020 | -76.34% | -26.95% | 0.74x | 3.81x | CA$-7.86 Million |
| 2021 | 70.34% | 120.02% | 0.48x | 1.22x | CA$20.14 Million |
| 2022 | -39.88% | -53.25% | 0.60x | 1.25x | CA$-12.09 Million |
| 2023 | -23.74% | -16.77% | 1.07x | 1.33x | CA$-6.34 Million |
| 2024 | 9.71% | 8.57% | 0.98x | 1.16x | CA$-80.67K |
| 2025 | 6.70% | 6.27% | 0.91x | 1.18x | CA$-1.01 Million |
Industry Comparison
This section compares Covalon Technologies Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,318,462,155
- Average return on equity (ROE) among peers: -126.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Covalon Technologies Ltd. (COV) | CA$30.73 Million | -49.08% | 0.18x | $38.48 Million |
| Bausch + Lomb Corp (BLCO) | $6.92 Billion | -3.76% | 0.94x | $5.65 Billion |
| Ocumetics Technology Corp (OTC) | $837.40K | -265.10% | 0.64x | $53.27 Million |
| ZEN Graphene Solutions Ltd (ZEN) | $34.55 Million | -112.00% | 0.10x | $53.43 Million |
About Covalon Technologies Ltd.
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more